BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35120817)

  • 1. A large multicenter propensity match study of sentinel lymph node biopsy feasibility in endometrioid variants of endometrial cancer.
    Capozzi VA; Rosati A; Vargiu V; Sozzi G; Cosentino F; Chiantera V; Scambia G; Berretta R; Fanfani F
    Eur J Surg Oncol; 2022 Jun; 48(6):1390-1394. PubMed ID: 35120817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
    Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
    Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
    Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
    Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
    Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and feasibility of minimally invasive sentinel lymph node staging using indocyanine green in the management of endometrial cancer.
    Mendivil AA; Abaid LN; Brown JV; Mori KM; Beck TL; Epstein HD; Micha JP; Goldstein BH
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():29-32. PubMed ID: 29529474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Obesity on Sentinel Lymph Node Mapping in Patients with apparent Early-Stage Endometrial Cancer: The ObeLyX study.
    Vargiu V; Rosati A; Capozzi VA; Sozzi G; Gioè A; Berretta R; Chiantera V; Scambia G; Fanfani F; Cosentino F
    Gynecol Oncol; 2022 May; 165(2):215-222. PubMed ID: 35314087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
    Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Extraordinary Location of Sentinel Lymph Nodes in a Patient with Endometrial Cancer.
    Comba C; Aslan E; Vatankulu B; Tatar Z; Demir AA; Demir O
    J Minim Invasive Gynecol; 2023 Aug; 30(8):613-614. PubMed ID: 37137423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.
    Zuo J; Wu LY; Cheng M; Bai P; Lei CZ; Li N; Zhang GY; Zhao D; Li B
    J Minim Invasive Gynecol; 2019; 26(6):1125-1132. PubMed ID: 30445188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of ICG and technetium does not improve sentinel lymph node detection in endometrial cancer: Results of the COMBITEC study.
    Cabrera S; Barahona-Orpinell M; Almansa-González C; Padilla-Iserte P; Bebia V; Martí L; Tejerizo-García Á; Domingo S; Gil-Moreno A
    Gynecol Oncol; 2021 Jul; 162(1):32-37. PubMed ID: 33992451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006).
    Altın D; Taşkın S; Ortaç F; Tokgözoğlu N; Vatansever D; Güler AH; Güngör M; Taşçı T; Beşe T; Turan H; Kahramanoğlu İ; Yalçın İ; Çelik Ç; Demirkıran F; Köse F; Arvas M; Ayhan A; Taşkıran Ç
    Gynecol Oncol; 2022 Mar; 164(3):492-497. PubMed ID: 35033380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy.
    Bollino M; Geppert B; Lönnerfors C; Falconer H; Salehi S; Persson J
    Int J Gynecol Cancer; 2020 Mar; 30(3):339-345. PubMed ID: 32075897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study.
    Bogani G; Papadia A; Buda A; Casarin J; Di Donato V; Gasparri ML; Plotti F; Pinelli C; Paderno MC; Lopez S; Perrone AM; Barra F; Guerrisi R; Brusadelli C; Cromi A; Ferrari D; Chiapp V; Signorelli M; Leone Roberti Maggiore U; Ditto A; Palaia I; Ferrero S; De Iaco P; Angioli R; Panici PB; Ghezzi F; Landoni F; Mueller MD; Raspagliesi F
    Gynecol Oncol; 2021 Apr; 161(1):122-129. PubMed ID: 33485641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
    Soliman PT; Westin SN; Dioun S; Sun CC; Euscher E; Munsell MF; Fleming ND; Levenback C; Frumovitz M; Ramirez PT; Lu KH
    Gynecol Oncol; 2017 Aug; 146(2):234-239. PubMed ID: 28528918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoendoscopic Single-Site Sentinel Lymph Node Detection in Endometrial Cancer.
    Demirayak G; Comba C; Özdemir İA
    J Minim Invasive Gynecol; 2018; 25(5):776. PubMed ID: 29146390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of the sentinel node mapping algorithm in endometrial cancer and correlation of its performance against endometrial cancer risk subtypes.
    Rajanbabu A; Agarwal R
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():77-80. PubMed ID: 29554604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
    Stephens AJ; Kennard JA; Fitzsimmons CK; Manyam M; Kendrick JE; Singh C; McKenzie ND; Ahmad S; Holloway RW
    Int J Gynecol Cancer; 2020 Mar; 30(3):305-310. PubMed ID: 31857439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer.
    Makroum AA; Lee YJ; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
    J Obstet Gynaecol Res; 2023 Aug; 49(8):2118-2125. PubMed ID: 37286510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.